Real-world Secukinumab Outcomes in Canadian HS Patients
NCT07282015 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 142
Last updated 2026-05-13
Summary
The HS-RISE study aims to assess real-world HS treatment outcomes and patterns, safety of secukinumab, and to describe the baseline characteristics of patients diagnosed with moderate-to- severe HS who are prescribed secukinumab in Canadian routine clinical practice.
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Novartis Pharmaceuticals · Novartis Pharmaceuticals
Eligibility
- Min Age
- 18 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-12-12
- Primary Completion
- 2028-02-11
- Completion
- 2028-02-11
Countries
- Canada
Study Locations
More Related Trials
-
Secukinumab Treatment for Moderate to Severe Hidradenitis Suppurativa
NCT07109765 ·Status: RECRUITING
-
Long Term Observational Study to Collect in a Real-world populatIon Data on the Treatment Pattern of secukinumAb in Adult Patients With Moderate to Severe Hidradenitis Suppurativa.
NCT05921994 ·Status: ACTIVE_NOT_RECRUITING
-
Efficacy and Safety of SCT650C in Participants With Moderate to Severe Hidradenitis Suppurativa
NCT07244510 ·Status: RECRUITING ·Phase: PHASE2
-
Short-term Treatment Satisfaction in Hidradenitis Suppurativa Patients Initiated on Cosentyx in Routine Clinical Practice in Saudi Arabia
NCT06785779 ·Status: RECRUITING
-
Study to Collect in a Real-world populatIon Data on the Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe Hidradenitis Suppurativa (HS) in Routine Clinical Practice in the Russian Federation
NCT06517732 ·Status: ACTIVE_NOT_RECRUITING
-
Open Label Study to Assess the Effect of Secukinumab in Moderate to Severe Papulopustular Rosacea
NCT03079531 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study to Explore the Safety, Tolerability, Efficacy, and Pharmacokinetics of LT-002-158 Tablets in Chinese Adult Patients With Hidradenitis Suppurativa
NCT06932003 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Study of the Immunomodulation in the Hidradenitis Suppurativa and Evaluation of a New Therapeutic Strategy
NCT05208099 ·Status: NOT_YET_RECRUITING
-
A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
NCT07244263 ·Status: RECRUITING ·Phase: PHASE2
-
Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa
NCT07170917 ·Status: RECRUITING ·Phase: PHASE2
-
Study to Evaluate Tulisokibart for Hidradenitis Suppurativa (MK-7240-012)
NCT06956235 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Study Investigating Long-term Treatment With Spesolimab in People With a Skin Disease Called Hidradenitis Suppurativa Who Completed a Previous Clinical Trial
NCT04876391 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Study of BDB-001 Injection in Patients With Moderate to Severe Hidradenitis Suppurativa (HS)
NCT05093855 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Treatment of Cryoinsufflation in Treatment of Hidradenitis Suppurativa
NCT05830149 ·Status: TERMINATED ·Phase: NA
-
Intralesional Diode Laser Treatment of Fistulas in Hidradenitis Suppurativa
NCT04508374 ·Status: UNKNOWN ·Phase: NA
-
Safety, Tolerability, Pharmacokinetics, Immunogenicity and Efficacy of STP705 in Adult Patients With Hypertrophic Scars
NCT05196373 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Study to Compare Two Treatments for Axillary Hidradenitis Suppurativa: Carbon Dioxide Laser Versus Surgical Deroofing
NCT02163746 ·Status: COMPLETED ·Phase: NA
-
Study of Efficacy and Safety of Investigational Treatment in Patients With Hidradenitis Suppurativa
NCT04989517 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Single Doses of SBT777101 in Subjects With Hidradenitis Suppurativa
NCT06361836 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
A Study to Assess Disease Activity and Safety of Subcutaneous Lutikizumab (ABT-981) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-Tumor Necrosis Factor (TNF) Therapy and Who Are Naïve to Biologic Therapy
NCT05139602 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Pathophysiological Basis of Hidradenitis Suppurativa
NCT06370052 ·Status: NOT_YET_RECRUITING
-
Safety and Efficacy of EXC 001 in Subjects Who Have Participated in Prior Studies of EXC 001
NCT01494922 ·Status: COMPLETED ·Phase: PHASE2
-
Hespecta Vaccination in HPV+ Tumors or Malignant Lesions
NCT02821494 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate RIST4721 in Hidradenitis Suppurativa (HS)
NCT05348681 ·Status: TERMINATED ·Phase: PHASE2
-
Capsule Microbiota Transplant Therapy for Hidradenitis Suppurativa
NCT06058520 ·Status: RECRUITING ·Phase: EARLY_PHASE1